| Literature DB >> 30567242 |
Eswari Vilayur1,2, Jillian de Malmanche3, Paul Trevillian1,2, David Ferreira4,5.
Abstract
Thrombotic microangiopathy (TMA) after renal transplantation can be a diagnostic challenge. TMA can occur with calcineurin inhibitors, allograft rejection, infection, mutations in complement regulatory proteins and autoimmunity. A 52-year-old male renal transplant recipient presented with extensive deep vein thrombosis. He developed transfusion-dependent microangiopathic haemolytic anaemia with thrombocytopenia. He did not respond calcineurin inhibitor cessation, eculizumab or plasma exchange. ADAMTS13 and complement levels were normal. Infection and autoimmune screens were negative. A diagnosis of metastatic adenocarcinoma was made on bone marrow biopsy. This represents a rare case of malignancy-associated TMA in a renal transplant recipient. Early diagnosis can facilitate the prompt initiation of chemotherapy which is the only treatment option. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: acute renal failure; haematology (incl blood transfusion); renal transplantation; respiratory cancer
Mesh:
Year: 2018 PMID: 30567242 PMCID: PMC6301462 DOI: 10.1136/bcr-2018-226707
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X